←
John De Vos7,916 posts
John De Vos avatar

John De Vos

@_jdevos_

#stemcells researcher | Director of Cell Processing Facility @umontpellier @CHU_Montpellier | #iPScells #lung | @stemgenomics

◷ Joined July 2009▧ 670 Photos and videos
Chubby♨️ avatar
⟳ John De Vos retweeted
Chubby♨️@kimmonismus·Nov 15

Talking about acceleration: In 13 months, the best AI agent went from completing 2.5% of real freelance projects on the Remote Labor Index to 41.3% with Claude Fable 5.2. These were paid projects that took human professionals 29 hours on average, with briefs provided and client calls excluded. So yeah, white collar work will get a wake-up in 2027.

Post attachment
Eric Topol avatar
⟳ John De Vos retweeted
Eric Topol@EricTopol·Nov 14

A 37-year-old woman with 10 years of abdominal pain. —The AI makes the diagnosis and recommends a successful treatment. —The physician "diagnosed a patient with a condition I had never diagnosed before and started treatment largely on the basis of the output of a chatbot." In today's @NEJM nejm.org/doi/full/10.1056/NE…

Post attachmentPost attachmentPost attachment
Fyodor Urnov avatar
⟳ John De Vos retweeted
Fyodor Urnov@UrnovFyodor·Nov 12

Cease doomscrolling and start joyreading: the amazing Cecilia Cotta - with her trademark courage and creativity - leads a team at Tessera to a major advance in the field: generating stable CAR-T cells in vivo using LNP mRNA delivery - a key step towards CAR-T scalability and affordability! Gregor- and Rosalindspeed, Tessera! cell.com/cell/fulltext/S0092…

Fyodor Urnov avatar
⟳ John De Vos retweeted
Fyodor Urnov@UrnovFyodor·Oct 18

A second report (both this year) of AAV-driven insertional mutagenesis in gene therapy. Two out of ~3,000 total who received AAV. = nonzero and concerning. But VERY low. = it's all about benefit-risk, folks.

NEJM@NEJMOct 18

Vo and colleagues report AAV integration in a paraspinal neoplasm after gene therapy. The integrated sequence retained a CAG promoter–enhancer and activated a developmental transcription factor. Read the full report: nej.md/4jVtf6z

Post attachment
John De Vos avatar
John De Vos@_jdevos_·Nov 8

⚠️ AAV insertional mutagenesis is a real oncogenic risk. Novartis reports 9 tumors among >6,000 Zolgensma-treated patients. Vector integration involving the GLI1 oncogene was detected in 2 cases. A critical safety signal for long-term AAV gene therapy surveillance. #GeneTherapy

Post attachment
John De Vos avatar
John De Vos@_jdevos_·Nov 2

🚨 Gilead/Kite has announced a partial clinical hold on the Ph2 PALISADES-1 and Ph3 PALISADES-2 trials of KITE-753 in rDLBCL following grade 3–4 ICANS. KITE-753 is a next-generation, dual targeting (CD19 and CD20) and dual costimulation (CD28 41BB). fiercebiotech.com/biotech/gi…

Post attachment
Gabriel Ocana-Santero avatar
⟳ John De Vos retweeted
Gabriel Ocana-Santero@OcanaSantero·Oct 28

Last night an AI agent performed brain surgery on a mouse. We gave it 19 gene therapy vectors in a spreadsheet, a mouse model of epilepsy, access to a motorize surgery rig with cameras and one goal: reduce seizures. It picked the drug. It picked the brain region. It derived the coordinates from three papers. Then it drove the stereotaxic arms into the brain and injected 250 nanolitres while watching the entry site through the rig camera for bleeding. A licensed vet gated every irreversible step and held a physical kill switch to stop the AI agent. Thread on what it decided, what it saw, and the moment it refused to let me override it. [Writing this on the spot out of excitement, but I've been 18hrs in front of my laptop coding and coordinating this, so keeping it brief and descriptive, more cohesive thoughts on this soon...]

Post attachment
Eric Billy 🇫🇷🇪🇺🦋 avatar
⟳ John De Vos retweeted
Eric Billy 🇫🇷🇪🇺🦋@EricBillyFR·Oct 27

Après des jours à dire que Parcoursup c’était une plate-forme de « matching »et que les filtres étaient définis par les universités et écoles, je découvre cette vidéo d’un prof et elle est juste parfaite. À visionner. 👇🏻👇🏻

Quel est le véritable problème avec #Parcoursup ? Un prof répond :

5:13
Naftali Kaminski avatar
⟳ John De Vos retweeted
Naftali Kaminski@KaminskiMed·Oct 21

Our "Single-cell multi-omics in IPF & COPD: from atlas to impact" is out! We provide a brief guide to analytic approaches, an overview of how the technologies impact our understanding of the 2 diseases, limitations, future directions. A 🧵 will follow publications.ersnet.org/cont…

Post attachment